GENELINK, INC HIRES DIRECTOR OF BUSINESS DEVELOPMENT FOR DIRECT SELLING/NUTRITION INDUSTRY WORLDWIDE TO ROLLOUT GENELINK'S PROPRIETARY GENETIC OXIDATIVE STRESS ASSESSMENT TEST
July 18, 2001

MARGATE, NJ - (Business Wire) - July 18, 2001- GeneLink,Inc. (OTC BB:GNLK-news), GeneLink BioSciences, Inc., The World's First Family Centered DNA Bank and Hereditary Genetic Information Service, today announced that it has entered into an agreement with Monte Taylor to act as Director of GeneLink's Business Development focusing on rolling out GeneLink's proprietary Genetic Profiling Assessments to the direct selling, nutrition and skin-care industries worldwide.

Mr. Taylor has over 20 years experience as a management and marketing executive, specializing in strategic marketing plans, business development and marketing communications for a variety of mid-sized and Fortune 500 companies. A long-time advocate of the direct selling/nutrition industry, Mr. Taylor has personally developed sales and distribution networks, numbering in the tens of thousands, for several direct selling companies. Mr. Taylor holds an MBA in marketing.

"I am very excited to be involved with GeneLink (says Mr. Taylor) our genetic technologies are at the forefront of a revolution - ultimately changing the way consumers choose their nutritional supplements. On the other side, GeneLink's genetic profiling techniques will help nutritional and skin-care companies assess their customer's individual needs - and then deliver more targeted, customized and scientifically based regimens. „You might call it 'nutragenetics.' The implications for just the $80 Billion plus nutritional products industry are extraordinary, and the revenue possibilities for GeneLink are staggering." 

John R. DePhillipo, Chairman of GeneLink BioSciences, Inc. adds, "GeneLink is very proud to have such a qualified marketing executive on our team. Mr. Taylor brings to the table a solid background, integrity, energy and a commitment to helping GeneLink achieve its revenue targets in the coming years." 

Forward-Looking Statements: This news release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a new "safe harbor" for these types of statements.

SOURCE: GeneLink BioSciences, Inc.